Khalid, Jihan M.

HRN: 28-62-45  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/25/2026
CEFTRIAXONE 1G (VIAL)
02/27/2026
03/06/2026
IV
2g
OD
Infected Breast Mass
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  BloodstreamSkin & Soft Tissue    Compliance to guidelines: